- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
238
7 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
238 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NVDA | US$124.91 | -15.2% | 98.2% | US$3.0t | US$173.78 | PE48.5x | E24.5% | 0.03% | Semiconductors | ||
ARES | US$198.08 | 1.1% | 61.5% | US$60.6b | US$195.00 | PE92.5x | E38.4% | 1.9% | Diversified Financials | ||
ONON | US$63.62 | 5.2% | 137.4% | US$20.2b | US$62.47 | PE147x | E29.7% | n/a | Consumer Durables | ||
ALNY | US$277.16 | 0.6% | 58.4% | US$35.3b | US$299.74 | PS17.1x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
NU | US$13.44 | 10.3% | 49.2% | US$60.3b | US$15.06 | PB8.5x | E25.2% | n/a | Banks | ||
MRVL | US$110.33 | -12.5% | 65.0% | US$92.4b | US$129.25 | PS17.8x | E69.5% | 0.2% | Semiconductors | ||
ITCI | US$127.00 | -0.06% | 86.2% | US$13.5b | US$127.45 | PS22x | E52.2% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$28.64 | -14.3% | -50.9% | US$16.3b | US$40.79 | PE13.9x | E24.3% | n/a | Tech | ||
KSPI | US$97.79 | 2.2% | 6.4% | US$18.4b | US$126.60 | PE9.9x | E20.8% | 6.7% | Diversified Financials | ||
EXE | US$102.72 | -3.1% | 33.5% | US$23.7b | US$117.39 | PE93.5x | E64.0% | 2.2% | Energy | ||
VRT | US$114.60 | -25.3% | 92.7% | US$41.5b | US$143.31 | PE74x | E26.8% | 0.1% | Capital Goods | ||
NTNX | US$68.01 | 4.4% | 19.1% | US$18.2b | US$81.89 | PS8.2x | E92.0% | n/a | Software | ||
SN | US$113.72 | 2.0% | 137.6% | US$15.7b | US$122.87 | PE44.4x | E22.4% | n/a | Consumer Durables | ||
CTRA | US$28.39 | -2.9% | 15.3% | US$20.8b | US$34.59 | PE16.9x | E25.2% | 3.0% | Energy | ||
RYAN New | US$66.61 | 3.7% | 55.6% | US$17.3b | US$73.98 | PE82x | E43.9% | 0.7% | Insurance | ||
ZS | US$202.83 | 5.3% | -14.8% | US$30.9b | US$226.04 | PS13.5x | E39.7% | n/a | Software | ||
DASH | US$188.57 | 3.0% | 75.7% | US$77.2b | US$186.03 | PS7.7x | E44.0% | n/a | Consumer Services | ||
SPOT | US$550.13 | 9.7% | 151.2% | US$108.9b | US$495.21 | PE152.4x | E30.0% | n/a | Media | ||
SRPT | US$114.44 | -3.9% | -6.8% | US$11.0b | US$185.16 | PE89.7x | E29.8% | n/a | Pharmaceuticals & Biotech | ||
XPEV | US$15.57 | 9.3% | 83.8% | US$14.1b | US$14.77 | PS2.8x | E56.7% | n/a | Automobiles | ||
CVNA | US$243.94 | 0.3% | 473.6% | US$51.8b | US$250.91 | PE1844x | E37.2% | n/a | Retail | ||
SE | US$123.38 | 5.9% | 204.9% | US$70.0b | US$128.06 | PE728.5x | E38.1% | n/a | Media | ||
HUBS | US$771.99 | 4.7% | 25.9% | US$40.2b | US$758.46 | PS15.9x | E41.3% | n/a | Software | ||
TEAM | US$266.95 | 0.5% | 4.7% | US$70.7b | US$290.55 | PS15.2x | E59.4% | n/a | Software |